Company Data
Prelude Therapeutics Incorporated
Ticker
PRLD
Current Price
$0.8859 -1.77%
Market Cap
$50.0M
Price Target
Refer to Report
Volume
69.7K
52wk Range
$0.6101 - $6.8
Overview
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.